<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>小药说药 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-05T23:25:53+08:00</updated>
  <subtitle>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>老朋友的新篇章：二甲双胍再战抗肿瘤免疫</title>
    <updated>2020-11-05T06:30:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/KyC7tKlbnbH3dd6AGdVpfg</id>
    <link href="https://mp.weixin.qq.com/s/KyC7tKlbnbH3dd6AGdVpfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一代肿瘤免疫药物：肿瘤免疫治疗当前的趋势转变</title>
    <updated>2020-11-03T06:10:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/0HGQhuPNf39ndgVGzS0fng</id>
    <link href="https://mp.weixin.qq.com/s/0HGQhuPNf39ndgVGzS0fng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>曾惊艳了世人的BiTEs，后续开发是否依然值得期待？</title>
    <updated>2020-11-01T06:26:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/KP0hbs6rd5wNUveuoc4p_g</id>
    <link href="https://mp.weixin.qq.com/s/KP0hbs6rd5wNUveuoc4p_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>腺相关病毒在基因治疗的研究进展和未来应用</title>
    <updated>2020-10-30T06:02:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/sNSnbA9Ha96nWGwHw8Qskw</id>
    <link href="https://mp.weixin.qq.com/s/sNSnbA9Ha96nWGwHw8Qskw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>COVID-19患者独特的免疫学特征</title>
    <updated>2020-10-28T06:10:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/aS-fdfm9H5A-b_N13jMU7A</id>
    <link href="https://mp.weixin.qq.com/s/aS-fdfm9H5A-b_N13jMU7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>T细胞导向疗法在实体瘤的挑战和机遇</title>
    <updated>2020-10-26T06:01:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/oLOTTJ6aTkRMgONds1SmlA</id>
    <link href="https://mp.weixin.qq.com/s/oLOTTJ6aTkRMgONds1SmlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向TREM2, 治疗阿尔茨海默症和增强ICB的新希望</title>
    <updated>2020-10-24T06:05:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/7iTbTDN098BRWlgKHwg2MQ</id>
    <link href="https://mp.weixin.qq.com/s/7iTbTDN098BRWlgKHwg2MQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GLP-1受体激动剂在非酒精性脂肪肝病中的研究进展</title>
    <updated>2020-10-22T06:02:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-22:/s/n_tdKFBB5p6Cem4UND6RlA</id>
    <link href="https://mp.weixin.qq.com/s/n_tdKFBB5p6Cem4UND6RlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤相关髓系细胞在乳腺癌中的作用</title>
    <updated>2020-10-20T06:55:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-20:/s/VQE9eVTaKhN7LfHQkyoZuA</id>
    <link href="https://mp.weixin.qq.com/s/VQE9eVTaKhN7LfHQkyoZuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>文章伴读：肿瘤相关巨噬细胞及相关靶向治疗</title>
    <updated>2020-10-20T06:55:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-20:/s/E7DU7oj47bQ5ZYN0i6wJBg</id>
    <link href="https://mp.weixin.qq.com/s/E7DU7oj47bQ5ZYN0i6wJBg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>开发中的新策略：第三代ADC</title>
    <updated>2020-10-18T06:02:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-18:/s/wpdrQgNiwdYyMCzjBGhkOA</id>
    <link href="https://mp.weixin.qq.com/s/wpdrQgNiwdYyMCzjBGhkOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>